Quantitative confirmation of testosterone and epitestosterone in human urine by LCQToF mass spectrometry for doping control

Testosterone T is the primary male sex hormone. In addition to the development of secondary sex characteristics, testosterone has anabolic effects including increases in muscle size and strength and increases in lean body mass, making it an attractive candidate to enhance athletic performance. In the case of exogenous administration of testosterone, the ratio of testosterone to its isomer, epitestosterone E, is elevated. WADA has set a standard for TEratios of 4.0 as indicative of possible exogenous testosterone administration. Typically, a sample that screens for a TEratio above that threshold is then subjected to quantitative confirmation by GCMS. This methodology, however, can limited due to sensitivity issues as well as a limited number of qualifying ions that can be used for unambiguous identification. We have developed a confirmation method which uses liquidliquid extraction, followed by room temperature Girard P derivatization, and analysis using LCMSToF. We observe a number of advantages over conventional GCMS analysis. Analysis time is decreased. Sensitivity is increased, resulting in limits of detection of 2 and 0.5 ngml for testosterone and epitestosterone, respectively. The number of diagnostic qualifier ions is also increased allowing more confident identification of the analytes. Finally, while this method has been developed on a QToF instrument, it should be easily transferable to any tandem LCMSMS system. Copyright © 2008 John Wiley & Sons, Ltd.